Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. (ELVN) — Form 10-Q: Quarterly report
About this filing
Enliven Therapeutics, Inc. (ELVN) filed Form 10-Q (quarterly report) with the SEC on Nov 5, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More ELVN filings
- 8-K
Filed Nov 5, 2026
- 4
Filed Nov 3, 2026
- SC 13G/A
Filed Oct 27, 2026
- 4
Filed Oct 21, 2026
- 4
Filed Oct 21, 2026
- 144
Filed Oct 19, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.